As incidence of acute lung injury (ALI) increases and case fatality decreases, long-term care of survivors is of public health importance. Previous studies demonstrate that these survivors are at risk for impairment in physical, cognitive and mental health. In this review, we will discuss recent studies that add to our knowledge of long-term outcomes after ALI and critical illness.
INTRODUCTION
As incidence of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) increases and case fatality decreases, we are living in times of unprecedented survivorship with over 100 000 ALI survivors each year in the United States alone. However, two decades of research have taught us that surviving ALI is not easy for most patients. Despite rapid and remarkable lung recovery with return to near-normal pulmonary function in the majority of survivors, most patients are left with new physical, cognitive, emotional and functional impairments [1 & ] . In this article, we review new research that fills knowledge gaps about duration of post-ALI impairment and related costs, identification of risk factors and the impacts of survivorship on ALI patients and their families. We discuss innovative studies of broader cohorts of survivors of critical illness that address the difficult issues surrounding the relationship between premorbid conditions and post-ICU impairment. We will conclude with a discussion of randomized trials, focusing on the unanswered question: 'When is the right time to improve outcomes after ALI and critical illness?'
PHYSICAL RECOVERY AND HEALTH-RELATED QUALITY OF LIFE 5 YEARS AFTER ACUTE RESPIRATORY DISTRESS SYNDROME
Nearly 20 years ago, McHugh et al. [2] created one of the first inception cohorts of ARDS survivors. They followed 52 patients for 1 year after acute hospitalization, assessing pulmonary function and health-related quality of life (HRQoL) at discharge, 3, 6 and 12 months. This landmark study found that although lung mechanics, volumes and diffusing capacity were initially abnormal in nearly all patients, forced vital capacity and total lung capacity returned to near normal in most patients by 12 months. Despite recovery of lung function, patients demonstrated profound impairments in HRQoL that persisted to 12 months and remained below that of a healthy population. These decrements in HRQoL were not generally attributed to lung-related issues.
To understand the specific contributors to decreased physical HRQoL and confirm McHugh et al.'s findings, Herridge et al. [3] in Toronto, Canada evaluated patients with severe ARDS. This cohort was young (median age 45 years), had few comorbidities and virtually all were working fulltime prior to their critical illness. Forty percent died in ICU and ICU LOS was almost 4 weeks. Survivors were evaluated at 3, 6 and 12 months, then yearly for a total of 5 years using pulmonary, exercise, HRQoL measures, pattern and cost of healthcare utilization and in-person history and physical examination. Consistent with previous studies, most patients returned to normal pulmonary function by 12 months. The novel contribution of this study was the primary attribution of persistent functional impairment and decrement in HRQoL to patient reports of muscle wasting, weakness and fatigue À and not pulmonary dysfunction À in previously young and high-functioning survivors of severe ARDS.
Five-year outcomes of the Toronto ARDS cohort have recently been published [4 && ]. Among the 64 patients who survived 5 years after ARDS and continued in the cohort, pulmonary function remained normal. The physical component summary score (PCS, in which SF-36 domains of physical functioning, role-physical and bodily pain contribute most) remained impaired, with the mean score approximately 1 SD below normal. There was no significant interval improvement after 12 months. The PCS was strongly associated with 6-min walk distance, which also remained substantially below predicted distances for the majority of patients; only 39% of survivors achieved a distance of at least 80% predicted. Patient perception of physical recovery, as measured by the PCS, was significantly more rapid among patients who were 52 years old or younger at the time of acute illness. By 5 years, almost all survivors had returned to their original work but with significant facilitation by the study team. Costs decreased significantly after the first year, but did not return to baseline levels of healthcare utilization for this young age group. Figure 1 presents the change over time in PCS score, 6-min walk distance, and medical costs. Structured interviews revealed a spectrum of persistent impairments experienced by patients and their caregivers, as listed below, and consistent with those published previously by Griffiths and Jones [5] for a diverse case mix of ICU survivors. Physical disorders after intensive care include [3, 5] (1) severe muscle wasting and weakness including decreased cough, pharyngeal weakness; (2) contractures, frozen joints; (3) heterotopic ossification; (4) alopecia; (5) numbness, paresthesia (peripheral neuropathy); (6) taste changes, decreased visual acuity, hearing loss/tinnitus; (7) sleep disturbances; (8) cardiac and circulatory decompensation: postural hypotension; (9) rare bronchiectasis and pulmonary fibrosis; (10) iatrogenic (a) tracheal stenosis, (b) entrapment neuropathies, dental caries and tooth loss, (c) scarring (CVC, arterial lines, CT drains) and (d) striae.
These important studies suggest that ARDS is more than an acute disease, for survivors often emerge with chronic physical functional limitations and associated reduced HRQoL. The perpetuation of these impairments appears to be independent of pulmonary recovery; many questions remain regarding causes, risk factors and possibilities for prevention and treatment. As these early cohorts predate widespread use of lung protective ventilation, it is unknown whether current patients with ALI and ARDS may experience markedly different outcomes. It is possible (although not proven) that current patients may experience less nerve and muscle injury during critical illness, experience fewer days of bed rest and mechanical ventilation, which may directly or indirectly improve short-term
KEY POINTS
Survivors of acute lung injury (ALI) have persisting impairment in physical and cognitive function 5 years after critical illness.
Critical illness is a risk factor of physical and cognitive functional decline, independent of premorbid function.
Glucose dysregulation may play a role in development of both depression and cognitive impairment.
Interventions delivered early in critical illness may be key in improving late outcomes after ALI.
and long-term outcomes. Large ongoing inception cohort studies, such as the ICAP study [6] , are well positioned to provide information about changes in the incidence and severity of physical functional impairment after ALI, as well as potential associations between premorbid and hospital exposures and outcome.
COGNITIVE AND EMOTIONAL FUNCTION
In addition to impaired physical function after ARDS, it has been shown that survivors are at risk for cognitive and emotional impairment as well. Pioneering work by Hopkins et al. [7] has exposed the tremendous burden of cognitive dysfunction after ARDS. First published in 1999, a consecutive series of survivors of severe ARDS performed detailed cognitive testing at hospital discharge and again in 1 year. Investigators discovered that all patients initially had significant impairments in at least one domain of cognitive testing. Twelve months later, 78% of survivors continued to demonstrate cognitive dysfunction with greatest impairments noted in domains of memory, attention and concentration. Another follow-up inception cohort confirmed these previous findings and noted additional dysfunction in the domains of processing speed and executive function [8] . Both studies sought to discover risk factors for cognitive impairment and found that hypotension and hypoxemia 
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were important associations early after critical illness but had no demonstrable relationship at 1-year follow-up. More recently, Hopkins et al. [9] have examined the relationship between blood glucose and cognitive function. Performing a secondary analysis of 66 of 74 hospital survivors of ARDS enrolled in a randomized clinical trial of higher versus lower tidal volume, cognitive sequelae (defined by two or more cognitive test scores that were greater than 1.5 SDs below normative population values) were noted in 70% of patients at hospital discharge. There was improvement up to 2 years with 46% of patients affected. Investigators found that blood glucose values higher than 153 mg/dl, higher blood glucose variability and duration of mechanical ventilation were associated with cognitive sequelae.
Not all brain dysfunction after ARDS is cognitive. Hopkins et al. [7] have shown that there are important psychological sequelae of critical illness, with anxiety [7, 10] , depression [7] and posttraumatic stress disorder (PTSD) [11] symptoms present in 20-40% of survivors. Risk factors for psychological dysfunction after ARDS are still unclear.
A large inception cohort study of ALI patients performed evaluation of depression 3 months after hospital discharge, finding significant independent associations with obesity (BMI >40 kg/m 2 ), preadmission depression or anxiety and hypoglycemia (mean daily blood glucose less than 100 mg/dl) [12] . Similarly, Hopkins et al. [13] evaluated potential risk factors for symptoms of depression and anxiety at 1À2 years after ARDS. Although mean scores on these assessments were within normal range, 16-24% of patients had scores consistent with moderate to severe depression and anxiety at 1À2 years. At 1 year, predictors of depression included alcohol dependence, female sex, younger age and presence of cognitive sequelae. Physiologic and ICU treatment variables were not significantly associated with depression. On the contrary, anxiety at 1 year was associated with duration of mechanical ventilation, smoking history and higher severity of illness as measured by the APACHE II. Little is known about persistence of depressive symptoms beyond 2 years after ALI; a recently completed study of the Toronto ARDS cohort suggests that there may be some improvement over time, but that moderateto-severe depressive symptoms persist in 19% of the patients 5 years later (N. Adhikari, personal communication).
These newer studies reinforce findings from earlier work that shows that cognitive and psychological impairment is common and important after critical illness, but also emphasize how much more work needs to be done. The finding by Dowdy et al.
[12] that preadmission depression and anxiety is the strongest independent predictor of depression is important, implying that obtaining a careful history of mental health history before critical illness may play a role in identifying patients at highest risk for psychological sequelae during recovery. Additionally, there is an important interplay between cognitive and psychological function; screening for cognitive impairment may be doubly crucial in survivors of ARDS [14] .
THE EXPERIENCE OF CRITICAL ILLNESS BY ACUTE RESPIRATORY DISTRESS SYNDROME SURVIVORS AND THEIR CAREGIVERS
Although evidence supporting the multifaceted challenges facing ARDS survivors and their families has grown, there are limited formal qualitative data chronicling this experience. In a powerful and innovative study, Cox et al. [15] enrolled 24 dyads of ARDS survivors and their informal caregivers in order to perform a semi-structured interview in the first year after critical illness. Participants were asked to talk about their ICU experiences and the impact of these experiences on their lives; the most important themes are (1) pervasive memories of critical care, (2) day-to-day impact of new disability, (3) critical illness defining the sense of self, (4) relationship strain and change and (5) ability to cope with disability.
Cox et al. found that 'patients and their caregivers demonstrated the pervasive, persistent nature of an acquired disability and its remarkable day-today impact on families'. Nearly every patient described the devastating impact of weakness; recall of traumatic events, consistent with PTSD and cognitive deficits were also discussed by many patients. Neither patients nor caregivers were prepared to deal with these newfound disabilities and impairments, and some even reported that their complaints to physicians had been summarily dismissed. These findings truly bring home the points that post-ICU sequelae may have tremendous bearing on the lives of ARDS survivors, and that there remains a sizeable gap in our care of these patients and their families.
NEUROMUSCULAR SEQUELAE AFTER ACUTE RESPIRATORY DISTRESS SYNDROME
There is a continuum of weakness in the ICU beginning within hours [16] , demonstrable with bedside testing at 7 days [17] , and persisting for years. Muscle atrophy, critical illness polyneuropathy and myopathy have each been implicated [18] . Previous cohort studies have attempted to find potentially modifiable risk factors for ICUacquired weakness and critical illness neuromyopathies; many have looked at exposure to corticosteroids and neuromuscular blocking agents because these agents can cause critical illness myopathy in animal models [19] . Results have not been consistent or conclusive, likely due to the methodologic limitations of these investigations [20] . Recent studies have performed secondary analyses of randomized controlled trials of these medications in order to bypass the problem of confounding by indication.
In a secondary analysis of the NIHÀNHLBI-NHLBIÀARDS network study of patients with persistent lung injury, Hough et al. [21] hypothesized that randomization to steroids could have led to an increase in ICU-acquired weakness or neuromyopathy. Thirty-four percent of patients with severe and persistent ARDS developed neuromyopathy during hospitalization. There was no statistically significant association of neuromyopathy at any time during the hospitalization (as assessed by medical record review) with randomization to methylprednisolone. However, intervention patients were more likely to have evidence of neuromyopathy in the first 28 days of the study, and were more likely to be clinically diagnosed with myopathy. It is unfortunate that the RCT did not include prospective and systematic assessment of muscle strength and electrophysiologic assessment of critical illness myopathy, for this could have been the opportunity to prove (or debunk) the association between steroids and ICU-acquired weakness. It was also a missed opportunity; there was no longterm follow-up of study participants that could have provided very strong evidence between the presence or absence of a causal role for steroids in the long-term physical functional impairment after ARDS.
A recent multicenter RCT was conducted to test the hypothesis that early treatment with neuromuscular blockers in the setting of early and severe ARDS may improve physiology, decrease ventilatorinduced lung injury and improve outcomes. Indeed, randomization to cisatracurium significantly decreased 90-day mortality from 40.7 to 31.6% [22] . Investigators included ICU-acquired weakness as a secondary outcome and attempted to evaluate all patients with protocolized manual muscle strength testing at day 28 and ICU discharge. At ICU discharge, there was no difference in average muscle strength among patients tested or in proportion with ICU-acquired weakness: 31% in placebo versus 36% in treatment group. Authors concluded that 'muscle weakness was not increased significantly by the use of the neuromuscular blocking agent in our study'. These findings are a substantial contribution, challenging the commonly held belief about the causal role of neuromuscular blockers in ICU-acquired weakness. However, there are some important limitations, including the use of manual muscle strength testing as the gold standard for investigating nerve and muscle function in the ICU [23 & ], and lack of follow-up testing to answer questions about lingering impairment.
LOOKING BEYOND ACUTE LUNG INJURY
In order to understand and improve long-term outcomes after ALI, we must look beyond observational inception cohorts of ALI survivors. Alternative study designs and broader populations can provide invaluable insight, including answers to questions: 'How do we know that most ALI outcomes are not simply premorbid?' and 'What interventions can improve long-term outcomes?'
Over the past year, four studies have identified preexisting longitudinal cohorts defined by characteristics other than critical illness and have then linked to data sources allowing classification of exposures such as critical illness hospitalization, mechanical ventilation or severe sepsis. Providing true premorbid assessment of cognitive function, depression and functional status, these studies provide the opportunity to use a patient's own baseline or trajectory of changing function before critical illness in adjustment, thus allowing interpretation of the independent association between critical illness and post-ICU outcomes.
Two studies evaluated cognitive function. In a Group Health Cooperative cohort of 2929 older individuals living independently without dementia, Ehlenbach et al. [24 && ] discovered that acute care and critical illness hospitalizations were independently associated with incident dementia, with an adjusted hazard ratio of 1.4 [95% cardiac index (CI) 1.1-1.7] for acute care and 2.3 (0.9-5.7) for critical illness hospitalization, compared with participants who did not require hospitalization. Additionally, global cognitive decline was more common among participants requiring hospitalization. As assessment of cognitive status required the ability to participate in assessment, the most severely affected individuals were lost by the cohort and unable to contribute in follow-up, so the magnitude of association is likely conservative. Using data from the health and retirement study, Iwashyna et al.
[25
&& ] linked the cohort to Medicare data, which they used to ascertain cases of severe sepsis. Among the 1194 patients included, severe sepsis was associated with an increased odds of 3.3 (95% CI 1.5-7.3) of moderate-to-severe cognitive impairment after controlling for baseline cognitive function and trajectory.
Davydow et al. [26 & ] examined the relationship between admission to the ICU and subsequent depression in a preexisting cohort of 3596 patients with diabetes enrolled in the pathways epidemiologic follow-up study of the group health cooperative. Ninety-eight patients were admitted to the ICU and had completed assessments both before and after critical illness. Among these patients, the point prevalence of probable major depression using the patient health questionnaire-9 was 14%, compared with 6% in those without ICU admission. In adjusted analyses, both ICU admission and pre-ICU probable major depression were both independently associated with post-ICU probable major depression. This study was underpowered to explore the potential of effect modification between premorbid depression and ICU admission on the outcome of post-ICU depression.
In a similar design, Barnato et al. [27 && ] used the population-based longitudinal cohort study of Medicare recipients (Medicare current beneficiary study) to investigate the association of mechanical ventilation and disability [27 && ]. The parent study conducted in-person interviews four times each year for 4 years, including a mobility difficulty score and a weighted activities of daily living (ADLs) score. In order to be included in the analytic cohort, beneficiaries had to be 65 years or older and dwelling in community. In order to contribute observations to the exposures of mechanical ventilation or hospitalization, a patient had to have prehospitalization and posthospitalization interviews available for analysis. Survivors of hospitalization with or without mechanical ventilation had similar levels of disability from each other, but significantly more than those who were never hospitalized. There was a substantial increase in disability in both groups after hospitalization, greater among survivors of mechanical ventilation than in those hospitalized without mechanical ventilation. In adjusted analyses, mechanical ventilation was associated with a 30% greater disability in ADL and a 14% greater disability in mobility.
These studies show that decrements in physical and mental function occur across the spectrum of critical illness and are not unique to survivors of ALI. The independent contribution of ALI to the prevalence, duration or severity of post-ICU impairment is still unclear.
STUDIES TO IMPROVE ICU AND LONG-TERM OUTCOMES AFTER CRITICAL ILLNESS
Although there are no published interventional studies designed to improve long-term outcomes after ALI, there have been four recent randomized controlled trials of critically ill patients focused on decreasing ICU sequelae. Schweickert et al. [28] randomized 104 mechanically ventilated patients with medical critical illness either to protocolized early physical and occupational therapy versus usual care. The primary endpoint was not long-term outcome, but rather functional status at hospital discharge, defined as the ability to perform six ADLs and to walk independently. All but three patients in the intervention group underwent physical and occupational therapy; therapy took place on 87% of study days and involved a daily protocol that progressed from active assistance of range of motion to bed mobility to ambulation as guided by patients' medical stability and tolerance. Randomization to the intervention group led to marked improvement in the primary outcome measure; 59% were functionally independent at hospital discharge, compared with 35% in the control group. Secondary outcomes demonstrated the positive effect of early therapy on duration of mechanical ventilation (3.4 days compared with 6.1), and the incidence and duration of delirium. Decrease in delirium may be especially important, given its association with important outcomes such as mortality and long-term cognitive impairment. These improved hospital outcomes have been corroborated by nonrandomized investigations [29] [30] [31] . Additionally, it has been shown that early mobility is associated with a decreased risk of hospital readmission and death in the first year after acute respiratory failure [32 & ]. Another common and debilitating problem after ALI and critical illness is PTSD. A recent investigation tested the hypothesis that a prospectively collected diary of a patient's ICU stay would decrease new-onset PTSD, because it has been proposed that the lack of complete and factual memories may be important in the development of PTSD [33 && ]. In this study of patients requiring at least 3 days in the ICU, 352 patients were randomized to the intervention of receiving their ICU diary 1 month after critical illness (if requested) or the control of receiving the diary after completion of follow-up evaluation at 3 months. The primary outcome measure was development of new PTSD, assessed with the PTSS-14 screening tool. Jones et al. found that early receipt of the ICU diary reduced new PTSD from 13% in the control group to 5% in the intervention group. These exciting studies suggest that physical, cognitive and psychological impairment may be reduced by interventions that begin in the ICU.
Other recent randomized controlled trials have attempted to improve post-ICU outcomes with interventions beginning after discharge from intensive care. Cuthbertson et al. [34] randomized 143 critical illness survivors at three UK hospitals to a manual-based physical rehabilitation program with nurse-led clinics, and the same number to standard care. This approach did not improve outcomes at 12 months, with no significant difference in HRQoL between the study groups, but considerably higher costs. Similarly, Elliott et al. [35 & ] recruited 195 survivors of mechanical ventilation from Australian hospitals to participate in an RCT of 8 weeks of endurance and strength training upon discharge to home in a program that included home visits by a physical trainer and follow-up phone calls [35 & ]. The primary outcome was the physical functioning scale of the SF-36; secondary outcomes included 6-min walk test distance and other aspects of HRQoL, using the physical and mental component summary scores. The intervention did not improve rate or extent of recovery over 26 weeks of follow-up in any of the primary or secondary outcomes.
Despite these disappointing results, these important studies demonstrate that it is possible to conduct studies intended to improve post-ICU outcome. Perhaps the take-home message is that improving survivorship and longer term morbidity cannot wait until after critical illness has subsided, but must be addressed from day 1 in the ICU. Figure 2 emphasizes the concept that rehabilitation needs to begin at the time of ICU admission and to continue through post-ICU care to early and late community readjustment.
CONCLUSION
Survivors of ALI À and perhaps of critical illness in general À are at risk for substantial and persistent impairment in physical, cognitive and mental health. It is still not known how to predict, prevent or treat these crippling sequelae, but it is clear that providers cannot wait until ICU or hospital discharge to try and improve long-term outcomes. Future research is needed to identify patients at highest risk, to uncover modifiable risk factors 
